Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 16 studies | 60% ± 20% | |
astrocyte | 11 studies | 31% ± 14% | |
glutamatergic neuron | 6 studies | 34% ± 20% | |
Mueller cell | 5 studies | 37% ± 19% | |
GABAergic neuron | 4 studies | 36% ± 10% | |
chondrocyte | 4 studies | 61% ± 21% | |
connective tissue cell | 4 studies | 38% ± 20% | |
differentiation-committed oligodendrocyte precursor | 3 studies | 48% ± 2% | |
endothelial cell | 3 studies | 31% ± 7% | |
interneuron | 3 studies | 24% ± 7% | |
GABAergic amacrine cell | 3 studies | 29% ± 7% | |
amacrine cell | 3 studies | 28% ± 10% | |
neural progenitor cell | 3 studies | 43% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 10 studies | 25% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 95% | 1223.56 | 2517 / 2642 | 45% | 10.68 | 314 / 705 |
breast | 16% | 61.93 | 75 / 459 | 83% | 92.28 | 924 / 1118 |
skin | 57% | 2848.84 | 1028 / 1809 | 41% | 26.89 | 193 / 472 |
ovary | 43% | 243.00 | 78 / 180 | 43% | 19.45 | 184 / 430 |
pancreas | 1% | 20.48 | 4 / 328 | 76% | 59.19 | 136 / 178 |
intestine | 27% | 77.69 | 260 / 966 | 46% | 18.25 | 241 / 527 |
lung | 13% | 57.90 | 78 / 578 | 54% | 25.56 | 624 / 1155 |
bladder | 24% | 66.52 | 5 / 21 | 38% | 14.37 | 193 / 504 |
adrenal gland | 51% | 254.76 | 132 / 258 | 10% | 4.27 | 23 / 230 |
stomach | 8% | 23.78 | 30 / 359 | 41% | 13.71 | 118 / 286 |
spleen | 44% | 209.94 | 106 / 241 | 0% | 0 | 0 / 0 |
esophagus | 1% | 1.58 | 9 / 1445 | 36% | 17.37 | 65 / 183 |
uterus | 12% | 41.37 | 20 / 170 | 22% | 15.73 | 99 / 459 |
eye | 0% | 0 | 0 / 0 | 25% | 5.09 | 20 / 80 |
tonsil | 0% | 0 | 0 / 0 | 24% | 12.27 | 11 / 45 |
thymus | 4% | 12.52 | 26 / 653 | 18% | 6.26 | 107 / 605 |
blood vessel | 19% | 129.88 | 255 / 1335 | 0% | 0 | 0 / 0 |
adipose | 16% | 148.09 | 194 / 1204 | 0% | 0 | 0 / 0 |
prostate | 7% | 27.96 | 17 / 245 | 2% | 0.35 | 8 / 502 |
muscle | 8% | 31.36 | 66 / 803 | 0% | 0 | 0 / 0 |
kidney | 2% | 5.88 | 2 / 89 | 6% | 1.91 | 51 / 901 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.52 | 2 / 29 |
liver | 0% | 0 | 0 / 226 | 2% | 1.46 | 8 / 406 |
heart | 1% | 7.27 | 8 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007601 | Biological process | visual perception |
GO_0007605 | Biological process | sensory perception of sound |
GO_0006029 | Biological process | proteoglycan metabolic process |
GO_0035989 | Biological process | tendon development |
GO_0048704 | Biological process | embryonic skeletal system morphogenesis |
GO_0035987 | Biological process | endodermal cell differentiation |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0055010 | Biological process | ventricular cardiac muscle tissue morphogenesis |
GO_0002063 | Biological process | chondrocyte development |
GO_0042472 | Biological process | inner ear morphogenesis |
GO_0030199 | Biological process | collagen fibril organization |
GO_0001503 | Biological process | ossification |
GO_0050910 | Biological process | detection of mechanical stimulus involved in sensory perception of sound |
GO_0001502 | Biological process | cartilage condensation |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005592 | Cellular component | collagen type XI trimer |
GO_0008201 | Molecular function | heparin binding |
GO_0030020 | Molecular function | extracellular matrix structural constituent conferring tensile strength |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_1904399 | Molecular function | heparan sulfate binding |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0050840 | Molecular function | extracellular matrix binding |
Gene name | COL11A1 |
Protein name | Collagen type XI alpha 1 chain Collagen XI alpha 1 Collagen alpha-1(XI) chain Mutant collagen XI alpha 1 variant isoform A |
Synonyms | CO11A1 COLL6 |
Description | FUNCTION: May play an important role in fibrillogenesis by controlling lateral growth of collagen II fibrils. |
Accessions | A0A2R8Y5N4 ENST00000647280.1 ENST00000635193.1 ENST00000447608.1 Q5IKE6 ENST00000512756.5 [P12107-4] Q5XNW2 A0A2R8Y4I5 H7C381 ENST00000645458.1 A0A0U1RRA7 ENST00000644186.1 P12107 Q5IKF0 C9JMN2 A0A2R8Y4M5 Q5XNW0 ENST00000358392.6 [P12107-2] ENST00000370096.9 [P12107-1] Q4FAC4 A0A2R8YDU3 ENST00000427239.5 ENST00000461720.6 Q5IKE9 ENST00000353414.8 [P12107-3] |